Trial
NCT02570503
Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Osteoarthritis, Knee
Intervention
Ropivacaine
Why stopped
Study's primary aims are no longer clinically impactful, as intrathecal morphine has fallen out of favor and replaced with different agents so that outpatient/23 hr surgery is more predictably achievable.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-04